Lauren Cornell, Ph.D.
Co-Founder and CEO
Lauren Cornell, Ph.D., is co-founder and CEO of NovoThelium, a biotechnology company developing acellular nipple-areolar grafts to improve breast reconstruction outcomes for mastectomy patients. A translational scientist specializing in regenerative medicine and biomaterials, she has guided NovoThelium from concept through preclinical development, earning patents, grant support, and national recognition, including induction into the Texas Business Hall of Fame. Lauren also served as an analog astronaut for NASA’s HERA program. She holds a Ph.D. in Translational Science, M.S. in Biomedical Engineering and B.S. in Genetics.